Responses
Clinical trials and drug discovery
Original research
Safety, immunological effects and clinical response in a phase I trial of umbilical cord mesenchymal stromal cells in patients with treatment refractory SLE
Compose a Response to This Article
Other responses
No responses have been published for this article.